DW5121

· Daewon Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DW5121, covering 2025-07-30 to 2025-07-30. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of DW5121 Compared to DW51211 and DW51212 [Phase 3]